- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about YMAB
Recent news which mentions YMAB
From InvestorPlace
Why Quanergy Systems Shares Are Trading Sharply Lower; Here Are 28 Stocks Moving Premarket
October 31, 2022
From Benzinga
FDA's AdComm Gives Thumbs Down To Pediatric Cancer Therapy
October 31, 2022
Tickers
YMAB
From Benzinga
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
October 28, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 27, 2022
From Benzinga
Why UserTesting Shares Are Trading Higher By Around 93%? Here Are 53 Stocks Moving In Thursday's Mid-Day Session
October 27, 2022
From Benzinga
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
October 27, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 26, 2022
From Benzinga
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
From Benzinga
FDA Advisory Committee Meeting Scheduled For October 28, 2022 To Review Y-mAbs' Refiling For Omburtamab
September 01, 2022
Tickers
YMAB
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
From Benzinga
From Benzinga
Earnings Scheduled For August 8, 2022
August 08, 2022
From Benzinga
From Benzinga
103 Biggest Movers From Yesterday
May 11, 2022
From Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
May 10, 2022
From Benzinga
From Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
From Benzinga
74 Biggest Movers From Yesterday
April 29, 2022
From Benzinga
48 Stocks Moving In Thursday's Mid-Day Session
April 28, 2022
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
78 Biggest Movers From Friday
February 14, 2022
From Benzinga
Crypto and stocks setups
February 13, 2022
From AC Investor Blog
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.